Evidence map›Paper›PMID 38137072›Full record

ArticleBrain sciences2023

Changes in Multiparametric Magnetic Resonance Imaging and Plasma Amyloid-Beta Protein in Subjective Cognitive Decline.

Qiaoqiao Xu, Jiajia Yang, Fang Cheng, Zhiwen Ning, Chunhua Xi, Zhongwu Sun

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Qiaoqiao XuDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Jiajia YangDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Fang ChengDepartment of Neurology, The Third Affiliated Hospital of Anhui Medical University (Hefei City First People's Hospital), Hefei 230061, China.
Zhiwen NingDepartment of Neurology, The Third Affiliated Hospital of Anhui Medical University (Hefei City First People's Hospital), Hefei 230061, China.
Chunhua XiDepartment of Neurology, The Third Affiliated Hospital of Anhui Medical University (Hefei City First People's Hospital), Hefei 230061, China.
Zhongwu SunDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Anhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CNThird People's Hospital of Hefei · CN

Funding

Clinical Medical Research Transformation Project of Anhui Provincial Science and Technology Department 202204295107020024the Basic and Clinical Cooperative Research Program of the Anhui Medical University-incubation project for the Third Affiliated Hospital 2022sfy001the Key Research and Development Projects of Anhui Province 202104j07020031the National Natural Science Foundation of China (81771154) 81771154the Natural Science Foundation of Anhui Province 1908085QH322the Scientific Research Fund project of Anhui Medical University 2021xkj222
6 · The paper itself

Abstract

The association between plasma amyloid-beta protein (Aβ) and subjective cognitive decline (SCD) remains controversial. We aimed to explore the correlation between neuroimaging findings, plasma Aβ, and neuropsychological scales using data from 53 SCD patients and 46 age- and sex-matched healthy controls (HCs). Magnetic resonance imaging (MRI) was used to obtain neuroimaging data for a whole-brain voxel-based morphometry analysis and cortical functional network topological features. The SCD group had slightly lower Montreal Cognitive Assessment (MoCA) scores than the HC group. The Aβ42 levels were significantly higher in the SCD group than in the HC group (

Indexed as

graph theorygray matter volumepercent amplitude offluctuationplasma amyloid-beta proteinsubjective cognitive decline

Identifiers

PMID38137072
PMCPMC10742209
OpenAlexW4388945085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.